{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:49:55Z","timestamp":1754164195627,"version":"3.41.2"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Field cancerization is poorly defined in dermatology. The author group previously proposed and applied a classification system in an original cohort to risk-stratify patients with field cancerization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>Apply the authors' classification system within a validation cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Patients with keratinocyte carcinoma history completed a survey regarding demographic information, medical history, and chemoprevention use. Patients were assigned a field cancerization class, and differences between validation and original cohorts were assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>A total of 363 patients were enrolled (mean age 67.4; 61.7% male). After comparing validation and original cohorts, there were differences in age between class II (<jats:italic toggle=\"yes\">p<\/jats:italic> = .02) and class IVb (<jats:italic toggle=\"yes\">p<\/jats:italic> = .047), and differences in chemoprevention use in class III (<jats:italic toggle=\"yes\">p<\/jats:italic> = .04). Similar to the original cohort, the validation cohort was associated with increases in total number of skin cancers in the last year (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001), 5 years (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001), lifetime (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001), years since first skin cancer (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001), and chemoprevention use (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001). In the validation cohort, there were increases in age (<jats:italic toggle=\"yes\">p<\/jats:italic> = .03) and immunocompromised status (<jats:italic toggle=\"yes\">p<\/jats:italic> = .04) with increasing class, which were not observed in the original cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Differences among field cancerization classes were similar in a validation cohort, further highlighting the importance of class-specific treatment and management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004314","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T13:00:30Z","timestamp":1720184430000},"page":"1091-1095","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Refining Field Cancerization: An Institutional Cohort Analysis of Patient Characteristics in a Validation Cohort"],"prefix":"10.1097","volume":"50","author":[{"given":"Sierra I.","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska;"},{"name":"University of Utah School of Medicine, Salt Lake City, Utah;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell A.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska;"},{"name":"Creighton University School of Medicine, Omaha, Nebraska;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Plampton","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School, Minneapolis, Minnesota;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaeli K.","family":"Samson","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Wysong","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Sutton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. Population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amepre.2014.08.036","article-title":"Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011","volume":"48","author":"Guy","year":"2015","journal-title":"Am J Prev Med"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamadermatol.2014.3307","article-title":"Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma","volume":"151","author":"Wehner","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamadermatol.2015.4215","article-title":"Redefinition of skin cancer as a chronic disease","volume":"152","author":"Sutton","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jaad.2018.06.044","article-title":"Chronic nonmelanoma skin cancers and health-related impairment: a case-control study","volume":"80","author":"Sutton","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/DSS.0000000000003844","article-title":"Skin cancer as a chronic disease: a retrospective cohort study validating impact on healthcare utilization and quality of life","volume":"49","author":"Plampton","year":"2023","journal-title":"Dermatol Surg"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DSS.0000000000004011","article-title":"Evaluating disease-specific quality of life and chemoprevention utilization in patients with more than one lifetime skin cancer","volume":"50","author":"Gart","year":"2024","journal-title":"Dermatol Surg"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin","volume":"6","author":"Slaughter","year":"1953","journal-title":"Cancer"},{"key":"R10-20250731","first-page":"1727","article-title":"A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications","volume":"63","author":"Braakhuis","year":"2003","journal-title":"Cancer Res"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2020.03.126","article-title":"Field cancerization: definition, epidemiology, risk factors, and outcomes","volume":"83","author":"Willenbrink","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/DSS.0000000000003700","article-title":"Refining the classification of field cancerization","volume":"49","author":"Kitrell","year":"2023","journal-title":"Dermatol Surg"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdv.14151","article-title":"From actinic keratosis to squamous cell carcinoma: pathophysiology revisited","volume":"31","author":"Fernandez Figueras","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jdv.14652","article-title":"Defining the actinic keratosis field: a literature review and discussion","volume":"32","author":"Figueras Nart","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.2007.08268.x","article-title":"Management of field change in actinic keratosis","volume":"157","author":"Vatve","year":"2007","journal-title":"Br J Dermatol"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/DSS.0000000000000292","article-title":"Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma","volume":"41","author":"Asgari","year":"2015","journal-title":"Dermatol Surg"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2020.03.127","article-title":"Field cancerization: treatment","volume":"83","author":"Cornejo","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamadermatol.2015.0502","article-title":"Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis: a randomized clinical trial","volume":"151","author":"Pomerantz","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R19-20250731","first-page":"w14026","article-title":"Swiss clinical practice guidelines on field cancerization of the skin","volume":"144","author":"Hofbauer","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol."}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:05:52Z","timestamp":1753999552000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004314","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"type":"print","value":"1076-0512"},{"type":"electronic","value":"1524-4725"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}